Evidence map›Paper›PMID 24951258›Full record

ArticleGut2015

CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis.

Yoku Hayakawa, Guangchun Jin, Hongshan Wang, Xiaowei Chen, Christoph B Westphalen, Samuel Asfaha, Bernhard W Renz, Hiroshi Ariyama, Zinaida A Dubeykovskaya, Yoshihiro Takemoto and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Gastric Stem Cell Biology and Helicobacter pylori Infection.Current topics in microbiology and immunology · 2023
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 5 countries.

Yoku HayakawaDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Guangchun JinDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Hongshan WangDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Xiaowei ChenDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Christoph B WestphalenDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Samuel AsfahaDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Bernhard W RenzDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Hiroshi AriyamaDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Zinaida A DubeykovskayaDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Yoshihiro TakemotoDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Yoomi LeeDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Ashlesha MuleyDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Yagnesh TailorDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Duan ChenDepartment of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Sureshkumar MuthupalaniDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Arthur ShulkesDepartment of Surgery, University of Melbourne, Austin Health, Melbourne, Australia.
Daniel L WorthleyDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Shigeo TakaishiDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan.
Timothy C WangDivision of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Columbia University · USColumbia University Irving Medical Center · USMassachusetts Institute of Technology · USKyushu University · JPLudwig-Maximilians-Universität München · DENorwegian University of Science and Technology · NOUniversity of Melbourne · AU

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8M
Role of Inflamation in Mouse Models of Gastric CancerR01CA093405 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, TIMOTHY CRAGIN · 2001 to 2016
$3.8M
Function and regulation of progastrin receptors on intestinal progenitorsR37DK052778 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, TIMOTHY CRAGIN · 2010 to 2019
$3.5M
IN VIVO PATHOGENESIS OF HELICOBACTER PYLORIR01AI037750 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1996 to 2009
$3.5M
Stem Cells and Gastric CancerR01CA120979 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, TIMOTHY CRAGIN · 2006 to 2010
$2.3M
FUNCTION AND REGULATION OF GASTRINR01DK052778 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WANG, TIMOTHY CRAGIN · 1997 to 2008
$1.8M
NCI NIH HHS P01 CA028842NCI NIH HHS R01 CA093405NCI NIH HHS R01CA093405NCI NIH HHS R01 CA120979NCI NIH HHS R01CA120979NIAID NIH HHS R01 AI037750NIAID NIH HHS R01AI37750NIDDK NIH HHS R01 DK052778NIDDK NIH HHS R01DK052778NIDDK NIH HHS R37 DK052778NIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

objectiveProgastrin is the incompletely cleaved precursor of gastrin that is secreted by G-cells in the gastric antrum. Both gastrin and progastrin bind to the CCK2 receptor (Cckbr or CCK2R) expressed on a subset of gastric epithelial cells. Little is known about how gastrin peptides and CCK2R regulate gastric stem cells and carcinogenesis. Interconversion among progenitors in the intestine is documented, but the mechanisms by which this occurs are poorly defined.

designWe generated CCK2R-CreERT mice and performed inducible lineage tracing experiments. CCK2R+ antral cells and Lgr5+ antral stem cells were cultured in a three-dimensional in vitro system. We crossed progastrin-overexpressing mice with Lgr5-GFP-CreERT mice and examined the role of progastrin and CCK2R in Lgr5+ stem cells during MNU-induced carcinogenesis.

resultsThrough lineage tracing experiments, we found that CCK2R defines antral stem cells at position +4, which overlapped with an Lgr5(neg or low) cell population but was distinct from typical antral Lgr5(high) stem cells. Treatment with progastrin interconverts Lgr5(neg or low) CCK2R+ cells into Lgr5(high) cells, increases CCK2R+ cell numbers and promotes gland fission and carcinogenesis in response to the chemical carcinogen MNU. Pharmacological inhibition or genetic ablation of CCK2R attenuated progastrin-dependent stem cell expansion and carcinogenesis.

conclusionsCCK2R labels +4 antral stem cells that can be activated and expanded by progastrin, thus identifying one hormonal trigger for gastric stem cell interconversion and a potential target for gastric cancer chemoprevention and therapy.

Indexed as

CarcinogenesisAnimalsCells, CulturedGastrinsMiceProtein PrecursorsPyloric AntrumReceptor, Cholecystokinin BStem Cellsbig gastrinGastrinsProtein PrecursorsReceptor, Cholecystokinin BGASTRIC CANCERGASTRINGASTRIN RECEPTORSINTESTINAL STEM CELL

Identifiers

PMID24951258
PMCPMC4627594
OpenAlexW2113474824

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.